Clinical Trial: Single-ascending Dose Study of HEC-151 Injection

U.S., Jan. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07376200) titled 'Single-ascending Dose Study of HEC-151 Injection' on Jan. 14.

Brief Summary: Evaluate the safety, tolerability, PK/PD and immunogenicity characteristics of a single subcutaneous HEC-151 Injection solution in healthy participants

Study Start Date: March 11

Study Type: INTERVENTIONAL

Condition: Healthy Adult Male

Intervention: DRUG: HEC-151 Injection and placebo

Subcutaneous injection in the abdominal area

DRUG: Degludec insulin

Subcutaneous injection in the abdominal area

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Sunshine Lake Pharma Co., Ltd.

Published by HT Digital Content Services with permission from Health Dail...